METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2

European Patent Office Patent

PATENT NO 1682907
APP PUB NO EP-1682907-A1
SERIAL NO

04765681

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for identifying a subject at risk of cardiac fibrosis or failure-prone cardiac hypertrophy, comprising: determining in a biological sample from said subject the level of a non-myocytical marker selected from the group consisting of galectin-3 and thrombospondin-2; comparing the level of said marker to a standard level; and determining a risk of cardiac fibrosis if the level of said marker is elevated compared to the standard level.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITEIT MAASTRICHTNLMINDERBROEDERSBERG 4-6 6211 LK MAASTRICHT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address
PINTO YIGAL M NL-9721 VH GRONINGEN

Cited Art Landscape

Load Citation